YOUR WELLNESS SPACEThe nutrition library
p+proof&priceMADE FOR INDIAAsk us
THE CATEGORY GUIDE

D-Mannose

A major prevention trial did not confirm the expected benefit.

D-mannose is a sugar marketed in urinary-health supplements. Its proposed use for preventing recurrent UTIs has received substantial attention, but a large placebo-controlled community trial changed the evidence picture.

Brand-independent category guide · Sources checked 2 November 2026
START HERE

Three things to remember

  1. A 2024 trial in 598 women did not find a significant reduction in medically attended UTIs.
  2. Prevention research does not establish treatment of an active infection.
  3. Grams, capsule count and additional ingredients matter for cost, not as proof of efficacy.

What the larger trial found

In the UK trial, community-dwelling women with recurrent UTIs received 2 g daily D-mannose or placebo for six months. A medically attended suspected UTI occurred in 51.0% versus 55.7%; the difference was not statistically significant. The authors did not recommend it for prevention in that population.

This is more informative than a seller quoting only older positive studies. It does not answer every possible formulation question, but it directly weakens a broad claim that routine D-mannose reliably prevents recurrence.

Sources: D-mannose for prevention of recurrent UTI: randomized clinical trial — Hayward et al., JAMA Internal Medicine, 2024 ↗

Pure powders and urinary-health blends

A single-ingredient powder makes declared content easier to see. Capsules can be more convenient to count, but several capsules may be included in one label serving. Sachets may contain flavouring or other ingredients.

In a blend with cranberry or botanicals, the total powder weight is not the D-mannose weight. Record its separately declared amount. Evidence for another ingredient cannot be used to silently restore a prevention claim for D-mannose itself.

Grams should be converted accurately

There is no established nutritional requirement for supplemental D-mannose. The 2 g trial amount is reported to explain the evidence, not to recommend taking it.

For a hypothetical capsule label, 500 mg equals 0.5 g. Four such capsules declare 2 g. If the serving is four capsules and the bottle contains 60, there are 15 servings, not 60. A scoop measured by volume is not a reliable weight unless the manufacturer supplies the corresponding mass.

Do not let a supplement delay care

An active UTI needs a treatment decision separate from supplement shopping. Recurrent infections, pregnancy, fever, blood in the urine or back pain under the ribs warrant medical assessment, with urgent care appropriate for concerning symptoms.

The prevention trial is not comprehensive safety evidence for children, pregnancy or every person with kidney disease. A product advertised as a simple sugar still needs an appropriate safety review when health conditions or medicines are relevant.

Sources: Urinary tract infections — NHS ↗ · D-mannose for prevention of recurrent UTI: randomized clinical trial — Hayward et al., JAMA Internal Medicine, 2024 ↗

A hypothetical powder-versus-capsule calculation

A 100 g powder pack costing ₹1,000 costs ₹10 per gram. A ₹750 bottle containing 60 capsules at 500 mg each contains 30 g in total, costing ₹25 per gram.

This establishes a price difference for the declared ingredient only. It is not a reason to consume more, nor a claim of cost-effective prevention. A supplement with uncertain benefit remains uncertain even when the price per gram is low.

The claim is part of product quality

A transparent product should state the D-mannose amount, other ingredients and relevant quality testing. Its description should acknowledge the larger negative prevention trial rather than promising an antibiotic-free cure.

When comparing India and international listings, keep currency, pack size and shipping separate from the clinical question. No number of capsules, premium sourcing claim or high review score can substitute for evidence that the intended use works.

Common questions

Why do some older descriptions sound more positive?

Earlier studies suggested benefit, but the larger 2024 placebo-controlled trial did not confirm prevention in community women with recurrent UTIs.

Is the trial amount a recommended daily intake?

No. It describes what researchers tested and helps interpret their result. It is not a personal dosing instruction.

WHEN YOU’RE READY TO COMPARE

Take the knowledge with you.

Compare the same form, active amount and intended use before comparing price. India and International listings have separate filters; some categories may have no listings in one market. Listings do not establish local stock or a need for a supplement. Shopping disclosures appear on product pages.

Sources & scope

This is a brand-independent editorial summary of the sources below, not an independent clinical review. Published reference values apply to their stated populations. Ingredient research does not verify a particular brand, batch or seller. No individual diagnosis, deficiency test or medical assessment is performed here.

Product photo credits & licences